K162793 is an FDA 510(k) clearance for the RHYTHMIA HDx Mapping System. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).
Submitted by Boston Scientific Corporation (Cambridge, US). The FDA issued a Cleared decision on March 10, 2017, 157 days after receiving the submission on October 4, 2016.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.
| 510(k) Number | K162793 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | October 04, 2016 |
| Decision Date | March 10, 2017 |
| Days to Decision | 157 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQK — Computer, Diagnostic, Programmable |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1425 |